2012国际卒中大会:卒中血管内治疗转归与ASPECTS相关

2012-02-17 MedSci MedSci原创

 2012国际卒中大会公布的START研究初步结果显示,CTA原始图像所示的治疗前艾伯塔卒中方案早期CT评分(ASPECTS)较高与血管内治疗后转归较好相关。NCCT与ASPECTS对比研究为确定其转归预测相对准确性所必需。   目前尚无用于选择患者行血管内卒中治疗(EVT)的标准成像方法。CT依然是应用最为广泛的卒中评价方法,并且ASPECTS定量的非强化CT缺血改变(NCCT

 2012国际卒中大会公布的START研究初步结果显示,CTA原始图像所示的治疗前艾伯塔卒中方案早期CT评分(ASPECTS)较高与血管内治疗后转归较好相关。NCCT与ASPECTS对比研究为确定其转归预测相对准确性所必需。


  目前尚无用于选择患者行血管内卒中治疗(EVT)的标准成像方法。CT依然是应用最为广泛的卒中评价方法,并且ASPECTS定量的非强化CT缺血改变(NCCT)可预测EVT的临床反应。

  START为一项前瞻性多中心研究,在接受EVT的患者中评估了治疗前核心卒中面积的临床影响。成像方法依据各患者实际情况而定,其中包括NCCT、CTA原始图像(CTA-SI)、CT灌注或MRI弥散成像。以盲法对ASPECTS进行分期,并依据既往分类方法(0-4,5-7,8-10)加以分析。临床转归被二分位90天改良Rankin量表评分为0-2和3-6。利用单变量和多变量分析确定转归预测因素。

  结果显示,在纳入的145例患者中,56例符合初步分析标准。平均年龄为(65.5±14.2)岁,中位NIHSS(美国国立卫生研究院卒中量表)为19.5。女性为30例(53.6%),靶血管阻塞为颈内动脉(ICA,14例)和大脑中动脉(MCA)M1段和M2段(41例)。CTA-SI所示的中位治疗前ASPECTS为6。评分为0-4、5-7和8-10的患者分别14(25%)、34(60.7%)和8例(14.3%)。TIMI 2-3血运重建率为87.3%。腹股沟穿刺至阿司匹林停药中位时间73.5分钟。

  27例(48.2%)患者实现良好90天转归;15例(26.8%)死亡。仅有1例(1.8%)患者出现症状性出血。CTA-SI所示治疗前ASPECTS较高与良好转归相关(P<0.05)。ASPECTS 0-4、5-7和8-10的良好转归(mRS 0-2)比率分别为21.4%、55.9%和62.5%(P=0.08)。对年龄和NIHSS校正之后,治疗前ASPECTS为良好转归的独立预测因子。在ROC分析中,治疗前ASPECTS>4为确认良好转归的最佳阈值(敏感性89%,特异性38%)。良好转归的其他单变量预测因素为低龄、低NIHSS、更远端阻塞以及腹股沟穿刺至阿司匹林停用时间较短。



相关链接:

International Stroke Conference

Late-Breaking Science Poster Abstracts:LB P3

Publishing Title:The Penumbra START Trial: Preliminary Results on the Clinical Impact of Pre-treatment CTA Source Image ASPECTS in Endovascularly-Treated Stroke Patients

Abstract :

Background: There is no standard imaging approach to select patients for endovascular stroke therapy (EVT). CT remains the most widely used modality for stroke evaluation, and ischemic change on noncontrast CT (NCCT) quantified using ASPECTS has been demonstrated to predict the clinical response to EVT. To date, there have been no good studies evaluating the influence of CTA source image (CTA-SI) pre-treatment ASPECTS (pre-ASPECTS) on outcomes following EVT.

Methods: START was a prospective multicenter study to evaluate the clinical impact of pre-treatment core infarct size in patients undergoing EVT using the Penumbra System. The imaging approach was left to each center‟s discretion, and included NCCT, CTA-SI, CT perfusion or MRI diffusion imaging. This study focused on the preliminary CTA-SI results. ASPECTS was graded in a blinded fashion and analyzed according to the a priori classification scheme (0-4, 5-7, 8-10), as well as using the entire scale. Clinical outcomes were dichotomized as 90-day modified Rankin Scale scores (mRS) of 0-2 (good) vs. 3-6. Univariate and multivariate analyses were performed to determine predictors of outcome.

Results:
Of the 145 patients enrolled, 56 met study criteria for this preliminary analysis. The mean age was 65.5 ± 14.2 years; median NIHSS was 19.5 (14-24). There were 30 (53.6%) females, and target vessel occlusions were in the ICA (n=14), MCA M1 & M2 segments (n=41). The median pre-ASPECTS on CTA-SI was 6 (4.5-7). There were 14 (25%) patients with scores of 0-4, 34 (60.7%) with 5-7, 8 (14.3%) with 8-10. The rate of TIMI 2-3 revascularization was 87.3% (48/55). The median time from groin puncture to discontinuation of aspiration was 73.5 (40-108) minutes. Twenty-seven (48.2%) patients achieved a good 90-day outcome. Fifteen (26.8%) died. Only one (1.8%) patient suffered a symptomatic hemorrhage. Higher pre-ASPECTS on CTA-SI was significantly associated with good outcomes (median 6 [IQR 5-7] vs. 5 [IQR 3-7], p<0.05). The rate of good outcomes (mRS 0-2) was 21.4% for ASPECTS 0-4, 55.9% for 5-7, and 62.5% for 8-10 (p=0.08). Adjusting for age and NIHSS, pre-ASPECTS was an independent predictor of good outcome (OR 1.5, p<0.04). In ROC analysis, ASPECTS >4 was the optimal threshold for identifying good outcomes (89% sensitivity, 38% specificity). Other univariate predictors of good outcome were lower age (p=0.02), lower NIHSS (p=0.02), more distal occlusion (p<0.05) and shorter time from groin puncture to stopping aspiration (p=0.02).

Conclusions:
These preliminary results show that higher pre-treatment ASPECTS on CTA source images is associated with better outcomes following endovascular therapy. Comparative studies versus NCCT ASPECTS are necessary to determine their relative accuracy for outcome prediction.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1647740, encodeId=6d84164e7408f, content=<a href='/topic/show?id=883828e714' target=_blank style='color:#2F92EE;'>#ASPECTS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2877, encryptionId=883828e714, topicName=ASPECTS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a37d23475396, createdName=liye789132259, createdTime=Thu Aug 23 15:07:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725406, encodeId=0c9c1e254067f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jul 22 15:07:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461920, encodeId=b645146192021, content=<a href='/topic/show?id=10bf5438bc' target=_blank style='color:#2F92EE;'>#CTS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5438, encryptionId=10bf5438bc, topicName=CTS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Feb 19 10:07:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1647740, encodeId=6d84164e7408f, content=<a href='/topic/show?id=883828e714' target=_blank style='color:#2F92EE;'>#ASPECTS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2877, encryptionId=883828e714, topicName=ASPECTS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a37d23475396, createdName=liye789132259, createdTime=Thu Aug 23 15:07:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725406, encodeId=0c9c1e254067f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jul 22 15:07:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461920, encodeId=b645146192021, content=<a href='/topic/show?id=10bf5438bc' target=_blank style='color:#2F92EE;'>#CTS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5438, encryptionId=10bf5438bc, topicName=CTS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Feb 19 10:07:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
    2012-07-22 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1647740, encodeId=6d84164e7408f, content=<a href='/topic/show?id=883828e714' target=_blank style='color:#2F92EE;'>#ASPECTS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2877, encryptionId=883828e714, topicName=ASPECTS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a37d23475396, createdName=liye789132259, createdTime=Thu Aug 23 15:07:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725406, encodeId=0c9c1e254067f, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Jul 22 15:07:00 CST 2012, time=2012-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461920, encodeId=b645146192021, content=<a href='/topic/show?id=10bf5438bc' target=_blank style='color:#2F92EE;'>#CTS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5438, encryptionId=10bf5438bc, topicName=CTS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Feb 19 10:07:00 CST 2012, time=2012-02-19, status=1, ipAttribution=)]
    2012-02-19 docwu2019

相关资讯

NEJM:研究发现亚临床房颤可增加卒中风险

近日,国际著名杂志The New England Journal of Medicine在线刊登了国外研究人员的最新研究成果“Subclinical Atrial Fibrillation and the Risk of Stroke,”文章中,研究者发现亚临床房颤可增加卒中风险。 大型国际随机ASSERT研究观察到两个重要结果,一是植入起搏器且无临床房颤(AF)史的老年高血压患者较常出现无

SWIFT试验:新型血流恢复装置卒中再通率高

 在2012年国际卒中大会上,美国多中心、随机对照、采用盲法确定主要终点的SWIFT试验表明,SOLITAIRE血流恢复装置对于无症状性出血的卒中成功再通率优于MERCI装置。与MERCI治疗相比,初始SOLITAIRE治疗与更多的再灌注、更少的症状性颅内出血、死亡率降低以及卒中后3个月更多的良好神经功能结局相关。   SOLITAIRE血流恢复装置是一种自膨式支架回收器,能够在急性脑缺血时促进

空气污染与卒中住院相关

  近日,2012国际卒中大会公布的有我国研究者参与的最新研究结果表明,在污染程度大于温暖季节50%的寒冷季节,暴露于NO2和PM10在各年龄组中均与卒中住院显著相关。    卒中为美国的第3大死因,中国的第1大死因。此项研究于中国武汉实施,其空气污染程度和污染范畴高于美国和欧洲的大城市。目前有关空气污染和脑血管疾病相关性的研究较为匮乏。此项研究获取了每日二氧化氮(NO2)、二氧化硫(

CNSR研究:高血压独立预测小动脉闭塞亚型卒中复发

 在2012年国际卒中大会上,来自我国首都医科大学天坛医院的一项临床研究证实,高血压是卒中小动脉闭塞(SAO)亚型复发独立预测因素,但非大动脉粥样硬化及心因性卒中亚型复发的预测因素。该研究强调了SAO亚型卒中患者控制高血压的重要性,旨在减少在中国人群中的卒中复发事件。   高血压能否导致缺血性卒中复发仍是全球激辩的热点问题,而中国关注于此的研究较少。中国国家卒中注册研究(CNSR研究)是中国第

AXIS-2研究:G-CSF治疗急性缺血性卒中

 2012年国际卒中大会上,来自德国的一项欧洲多中心、随机、双盲、对照研究(AXIS-2研究,NCT00927836)评价了AX200对急性缺血性卒中的有效性。   AX200(粒细胞集落刺激因子,G-CSF)是一种用于治疗急性卒中的候选药物,该药物涉及了一种新型、多模式急性病理生理和促进恢复的机制。Ⅱa期临床研究显示了在较大剂量范围内,AX200对卒中患者的安全性和耐受性。AXIS-2的主

2012国际卒中大会:新型免提超声装置与tPA联合溶栓安全有效

 2012国际卒中大会公布的最新研究结果表明,应用新型免提超声溶栓装置与组织型纤溶酶原激活物(tPA)联用具有较好的安全性,并且有较高的血管再通率。此种联合疗法值得在Ⅲ期有效性试验中进一步评估。   当与静脉(IV)-tPA联用时,经FDA批准的手持式经颅多普勒(TCD)超声装置可改善再通。免提经颅超声和全身t-PA脑出血联合溶栓(CLOTBUST-HF)研究是首次在人类中实